Multiorgan Failure From Nivolumab and Ipilimumab: A Case Report and Literature Review

Immune checkpoint inhibitors (ICIs) as standard of care have revolutionized the treatment of patients with metastatic melanoma. The combination of nivolumab and ipilimumab improves treatment efficacy and prolongs survival compared to monotherapy alone. However, combination therapy is also associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Brazel, Danielle, Lee, Seungshin, Mahadevan, Aditya, Warnecke, Brian, Parajuli, Ritesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419328/
https://www.ncbi.nlm.nih.gov/pubmed/37575835
http://dx.doi.org/10.7759/cureus.41781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419328/
https://www.ncbi.nlm.nih.gov/pubmed/37575835
http://dx.doi.org/10.7759/cureus.41781

Ejemplares similares